Our findings also revealed that relative to women without CE and CE patients with CD138 1–4/10 HPFs, CE patients with CD138 ≥5/10 HPFs had significantly higher levels of VEGFA and its receptor, VEGFR2. This evidence concerns the gene VEGFA and cholesteryl ester measurement.